fda glp-1 safety alert october 2025 US removes suicidal thoughts warning from weight-loss drugs November 2025 Drug Safety: Recalls

Experimental studies have explored its effects on: Tendons Ligaments Muscles Connective tissue Blood vessel development Most of these findings come from animal studies, so more human research is needed

Most recently, in March 2025, the district court denied the plaintiffs motion for a preliminary injunction, finding FDAs decision to remove tirzepatide from the drug shortage list was proper

In this particular group of patients who are older, who are diabetics, I really would caution against the extended use of GLP-1s, she said

Ali Rezaie, Medical Director of Gastroenterology Motility at Cedars-Sinai Medical Center, emphasized the need for context, noting that while the relative risk increases by 33%, the absolute risk remains low at 0.2%